1.Examine strengths and weaknesses of dual vs triple therapy in patients with COPD

2.Judge whether the current evidence warrants any change in treating patients with COPD in routine clinical practice.

3. Understand risk of a fib by age and standard cardiac risk factors

4. Understand how this risk is potentially modifiable

Session date: 
06/04/2018 - 12:00pm to 1:00pm CDT
UCMC L-431
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Drs. Jason Alexander & Andrew Davis